Artboard 33 Artboard 16 Artboard 18 Artboard 15 Artboard 21 Artboard 1 Artboard 2 Artboard 5 Artboard 45 Artboard 45 Artboard 22 Artboard 9 Artboard 23 Artboard 17? Artboard 28 Artboard 43 Artboard 49 Artboard 47 Artboard 38 Artboard 32 Artboard 8 Artboard 22 Artboard 5 Artboard 25 Artboard 1 Artboard 42 Artboard 11 Artboard 41 Artboard 13 Artboard 23 Artboard 10 Artboard 4 Artboard 9 Artboard 20 Artboard 6 Artboard 11 Artboard 7 Artboard 3 Artboard 3 Artboard 12 Artboard 25 Artboard 34 Artboard 39 Artboard 24 Artboard 13 Artboard 19 Artboard 7 Artboard 24 Artboard 31 Artboard 4 Artboard 14 Artboard 27 Artboard 30 Artboard 36 Artboard 44 Artboard 12 Artboard 17 Artboard 17 Artboard 6 Artboard 27 Artboard 19 Artboard 30 Artboard 29 Artboard 29 Artboard 26 Artboard 18 Artboard 2 Artboard 20 Artboard 35 Artboard 15 Artboard 14 Artboard 48 Artboard 50 Artboard 26 Artboard 16 Artboard 40 Artboard 21 Artboard 29 Artboard 10 Artboard 37 Artboard 3 Artboard 3 Artboard 46 Artboard 8

Science Lessons - What The Business Of Biotech Taught Me About Management (Cód: 9188805)

Binder,Gordon

Harvard Business Review Press

Ooopss! Este produto está temporariamente indisponível.
Mas não se preocupe, nós avisamos quando ele chegar.

Ooops! Este produto não está mais a venda.
Mas não se preocupe, temos uma versão atualizada para você.

Ooopss! Este produto está fora de linha, mas temos outras opções para você.
Veja nossas sugestões abaixo!

R$ 147,20 em até 4x de R$ 36,80 sem juros
Cartão Saraiva R$ 139,84 (-5%) em até 1x no cartão ou em até 7x de R$ 21,03 sem juros

Crédito:
Boleto:
Cartão Saraiva:

Total: R$0,00

Em até 4x sem juros de R$ 0,00


Science Lessons - What The Business Of Biotech Taught Me About Management

R$147,20

Descrição

Widely regarded as the most innovative, successful biotech firm ever, Amgen led its industry in revenue and sales growth in 2007. Top magazines including 'Fortune' and 'Industry Week' have repeatedly named it one of America's best companies to work for.
In 'Science Lessons,' Gordon BinderCEO and chairman during 1988-2000describes Amgen's climb to success. Revealing the highs and lows it experienced in the race to develop blockbuster drugs, he takes readers from the time Amgen had just three months of capital in the bank and no viable products in the pipeline to its spectacular success. The turning point? The 1989 launch of Epogen, which dramatically helped kidney dialysis patients suffering from debilitating anemia. Other landmark drugs, including Neupogen, would follow.
Through engaging anecdotes and cogent insights, Binder weaves a fascinating tale while offering his unique brand of practical management advice. Using the principals of the scientific method, he shares his recommendations for tackling pressing business challengessuch as managing creative employees, navigating the IPO process, and protecting intellectual property.
This colorful first-person account showcases the visionary science and daring business strategy that made Amgen greatoffering valuable lessons for all companies.'

Características

Produto sob encomenda Não
Marca Harvard Business Review Press
Cód. Barras 9781591398615
Altura 21.16 cm
I.S.B.N. 9781591398615
Profundidade 2.79 cm
Referência 9781591398615
Acabamento Capa dura
Ano da edição 2008
Idioma Inglês
Número de Páginas 292
Peso 0.48 Kg
Largura 14.55 cm
AutorBinder,Gordon